FA2H Gene SPG35 Genetic Test
At DNA Labs UAE, we offer the FA2H Gene SPG35 Genetic Test for individuals who may be affected by hereditary spastic paraplegia (HSP). This test can help diagnose SPG35 and provide valuable information about the condition.
Test Components
The FA2H Gene SPG35 Genetic Test includes the following components:
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Test Cost
The cost of the FA2H Gene SPG35 Genetic Test is AED 4400.0.
Test Details
The FA2H gene, also known as the fatty acid 2-hydroxylase gene, is associated with a specific type of hereditary spastic paraplegia called SPG35. HSP is characterized by progressive weakness and stiffness of the legs due to degeneration of the nerve fibers that control muscle movement.
NGS (Next-Generation Sequencing) genetic testing is used to analyze multiple genes simultaneously. In the context of SPG35, NGS genetic testing can identify mutations or variations in the FA2H gene that may be responsible for the development of the condition.
NGS genetic testing can help confirm a diagnosis of SPG35, provide information about disease prognosis, inheritance patterns, and potential treatment options. It can also be used for carrier testing and prenatal diagnosis in families with a known FA2H gene mutation.
Before undergoing the FA2H SPG35 NGS genetic test, it is important to consult with a healthcare professional or genetic counselor to understand the benefits, limitations, and implications of the test.
Pre Test Information
Prior to the FA2H Gene SPG35 NGS Genetic DNA Test, it is recommended to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with FA2H Gene SPG35.
For more information or to schedule an appointment, please contact DNA Labs UAE.
Test Name | FA2H Gene SPG35 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for FA2H Gene SPG35 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with FA2H Gene SPG35 |
Test Details |
The FA2H gene, also known as the fatty acid 2-hydroxylase gene, is associated with a specific type of hereditary spastic paraplegia called SPG35. Hereditary spastic paraplegia (HSP) is a group of genetic disorders characterized by progressive weakness and stiffness of the legs (paraplegia) due to degeneration of the nerve fibers that control muscle movement. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of SPG35, NGS genetic testing can be used to identify mutations or variations in the FA2H gene that may be responsible for the development of the condition. By identifying specific genetic changes in the FA2H gene, NGS genetic testing can help confirm a diagnosis of SPG35 and provide important information about disease prognosis, inheritance patterns, and potential treatment options. It can also be used for carrier testing and prenatal diagnosis in families with a known FA2H gene mutation. It is important to consult with a healthcare professional or genetic counselor to understand the benefits, limitations, and implications of FA2H SPG35 NGS genetic testing before undergoing the test. |